Cancer clinical trials in the region Grand Est
156 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Lung cancer
#NCT05048797
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
HER2
Systemic Treatment-Naive
ALK
EGFR
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Centre hospitalier universitaire François Mitterrand (Dijon), Centre Hospitalier du Mans (Le Mans), Hôpital Nord de Marseille (Marseille Cedex 20) (and 2 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT05078047
HER2 Negative
HR Negative
Metastatic
Immunotherapy
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Henri-Mondor AP-HP (Créteil) (and 16 more...)
UNICANCER
Phase 3
Lung cancer
#NCT05078047
Metastatic
Immunotherapy
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Henri-Mondor AP-HP (Créteil) (and 14 more...)
UNICANCER
Phase 3
Lung cancer
#NCT05261399
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
MET
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire Angers (Angers ), Hôpital Avicenne - AP-HP (Bobigny), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ) (and 10 more...)
AstraZeneca
Phase 3
Lung cancer
#NCT06140836
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
EGFR
BRAF
MET
HER2
ALK
RET
KRAS G12C
KRAS non G12C
PIK3CA
NTRK-1/2/3
Targeted therapy
Targeted therapy
Centre Hospitalier Universitaire Laennec (Saint-Herblain), Hôpital Cochin (Paris ), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre hospitalier universitaire François Mitterrand (Dijon) (and 3 more...)
Bristol-Myers Squibb
Phase 2 / Phase 3
Pancreas cancer
#NCT05254171
Adenocarcinoma
Metastatic
Systemic Treatment-Naive
BRCA 1/2
Centre François Baclesse (Caen ), Centre Hospitalier Universitaire de Toulouse (Toulouse), Hôpital de la Timone AP-HM (Marseille), Centre Hospitalier Universitaire de Besançon (Besançon)
Panbela Therapeutics Inc
Phase 2 / Phase 3
Colon cancer
Rectal cancer
#NCT05462613
Metastatic
Chemotherapy
Surgery
Targeted therapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris), Hôpital Nord de Franche Comté (Trévenans), Institut Mutualiste Montsouris (Paris), Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Henri-Mondor AP-HP (Créteil) (and 4 more...)
CHU de Besançon
Phase 2
Lung cancer
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
#NCT06162221
KRAS G12C
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Hôpital Louis Pradel (Bron ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille), Centre Hospitalier Universitaire de Nantes (Nantes) (and 1 more...)
Revolution Medicines, Inc.
Phase 2
Kidney cancer
#NCT04924075
Clear cell carcinoma
Localized
Locally Advanced
Von Hippel-Lindau syndrome (VHL)
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Paoli-Calmettes (Marseille), Hôpital Bicêtre AP-HP (Le Kremlin-Bicêtre), Hôpital Cochin (Paris ), Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon), Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg) (and 1 more...)
Merck Sharp & Dohme LLC
Phase 2
Pancreas cancer
#NCT04924075
Neuroendocrine tumor
Locally Advanced
Metastatic
Targeted therapy
Systemic Treatment-Naive
Surgery
Radiotherapy
Radiochemotherapy
Institut Paoli-Calmettes (Marseille), Hôpital Bicêtre AP-HP (Le Kremlin-Bicêtre), Hôpital Cochin (Paris ), Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon), Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg) (and 1 more...)
Merck Sharp & Dohme LLC